Christian F Singer - JoVE Visualize

Showing results (91-100 of 297) with videos related to

Pageof 30

Sort By:

BMC Cancer|February 19, 2016

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trialChristiane Thallinger, Istvan Lang, Cvetka Grasic Kuhar, et al.

Maturitas|September 7, 2012

A cross-sectional study of elderly Asian and European women with primary operable breast cancer aged 70 and older. Are there differences?Muy-Kheng M Tea, Lichen Tang, Gen-Hong Di, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.

Journal of Cancer Research and Clinical Oncology|September 2, 2008

Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?Gernot Hudelist, Pia Wuelfing, Klaus Czerwenka, et al.

Wiener Klinische Wochenschrift|June 26, 2015

AGO Austria recommendations for genetic testing of patients with ovarian cancerChristian Marth, Michael Hubalek, Edgar Petru, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast densityChristopher C Riedl, Nikolaus Luft, Clemens Bernhart, et al.

Journal of Cancer Research and Clinical Oncology|November 27, 2008

HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancerChristian F Singer, Daphne Gschwantler-Kaulich, Anneliese Fink-Retter, et al.

Reproductive Biomedicine Online|April 17, 2010

Administration of betaHCG leads to dose-dependent changes of gene expression signature of endometriotic stromal cellsGernot Hudelist, Ambros Huber, Michael Auer, et al.

Journal of Clinical Medicine|May 13, 2026

Management of Bone-Only Progressive Disease in Metastatic Breast Cancer-A Retrospective Single-Center AnalysisChristine Deutschmann, Paola Clauser, Florian Heinzl, et al.

European Journal of Cancer (Oxford, England : 1990)|December 6, 2005

Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Daphne Gschwantler-Kaulich, et al.

Pageof 30

Showing results (91-100 of 297) with videos related to

Sort By:

Pageof 30

BMC Cancer|February 19, 2016

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trialChristiane Thallinger, Istvan Lang, Cvetka Grasic Kuhar, et al.

Maturitas|September 7, 2012

A cross-sectional study of elderly Asian and European women with primary operable breast cancer aged 70 and older. Are there differences?Muy-Kheng M Tea, Lichen Tang, Gen-Hong Di, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.

Journal of Cancer Research and Clinical Oncology|September 2, 2008

Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?Gernot Hudelist, Pia Wuelfing, Klaus Czerwenka, et al.

Wiener Klinische Wochenschrift|June 26, 2015

AGO Austria recommendations for genetic testing of patients with ovarian cancerChristian Marth, Michael Hubalek, Edgar Petru, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast densityChristopher C Riedl, Nikolaus Luft, Clemens Bernhart, et al.

Journal of Cancer Research and Clinical Oncology|November 27, 2008

HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancerChristian F Singer, Daphne Gschwantler-Kaulich, Anneliese Fink-Retter, et al.

Reproductive Biomedicine Online|April 17, 2010

Administration of betaHCG leads to dose-dependent changes of gene expression signature of endometriotic stromal cellsGernot Hudelist, Ambros Huber, Michael Auer, et al.

Journal of Clinical Medicine|May 13, 2026

Management of Bone-Only Progressive Disease in Metastatic Breast Cancer-A Retrospective Single-Center AnalysisChristine Deutschmann, Paola Clauser, Florian Heinzl, et al.

European Journal of Cancer (Oxford, England : 1990)|December 6, 2005

Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Daphne Gschwantler-Kaulich, et al.

Pageof 30